ALAlign Technology company profile
$168.32+0.81%Close 13 Nov 2026 · Market value $11.84B
About Align Technology
Align Technology is a global medical device company engaged in designing, manufacturing and marketing Invisalign clear aligners for treating malocclusions, Vivera retainers, iTero intraoral scanners and related dental services, and exocad CAD/CAM software. Its products are sold mainly through a dedicated sales force to orthodontists, general dental practitioners, dental laboratories and dental support organizations, with sales agents and distributors used in certain countries. Clear aligners account for approximately 80% of worldwide net revenues, and Imaging Systems and CAD/CAM Services for the remaining 20% in the year ended December 31, 2025. The company also sells Invisalign accessory products through online, retail and pharmacy channels. Regional headquarters are located in Raleigh, Rotkreuz and Singapore, serving the Americas, EMEA and APAC.
A summary of the business section of the company's latest annual report, filed 27 Feb 2026.
Company facts
| Ticker | ALGN · Nasdaq |
|---|
| Sector | Medical devices |
|---|
| Industry | Health Care Supplies |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1097149 |
|---|
| Latest annual report | 10-K, filed 27 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Joseph M. Hogan | President and CEO · Director | 266K · < 1% | Shares withheld for tax, 20 Feb 2026 |
|---|
| Joseph Lacob | Director | 136K · < 1% | Option exercise, 20 May 2026 |
|---|
| C. Raymond Larkin, Jr. | Director | 27.5K · < 1% | Option exercise, 20 May 2026 |
|---|
| Andrea L. Saia | Director | 17.3K · < 1% | Option exercise, 20 May 2026 |
|---|
| Kevin J. Dallas | Director | 16.2K · < 1% | Option exercise, 20 May 2026 |
|---|
| Stuart Hockridge | EVP, GLOBAL HR | 14.9K · < 1% | Option exercise, 20 Feb 2026 |
|---|
| John F. Morici | EVP, CHIEF FINANCIAL OFFICER | 13.5K · < 1% | Option exercise, 20 Feb 2026 |
|---|
| Julie Coletti | EVP, CHIEF LEGAL & REGULATORY | 11.4K · < 1% | Shares withheld for tax, 20 Feb 2026 |
|---|
| Susan E. Siegel | Director | 10.7K · < 1% | Option exercise, 20 May 2026 |
|---|
| Anne M. Myong | Director | 9.8K · < 1% | Option exercise, 20 May 2026 |
|---|
| George J. Morrow | Director | 8.3K · < 1% | Option exercise, 20 May 2026 |
|---|
| Kevin T. Conroy | Director | 3.6K · < 1% | Option exercise, 20 May 2026 |
|---|
| Mojdeh Poul | Director | 3.6K · < 1% | Option exercise, 20 May 2026 |
|---|
| Britt Vitalone | Director | 1.4K | Option exercise, 20 May 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
ALGN in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.